Thrombosis and Haemostasis, Table of Contents Thromb Haemost 2006; 95(03): 399-400DOI: 10.1160/TH06-01-0043 Editorial Focus Schattauer GmbH D-dimer: Standardization versus harmonization Carl-Erik Dempfle 1 Mannheim University Hospital, Ist Department of Medicine, Mannheim, Germany › Author Affiliations Recommend Article Abstract Buy Article Full Text References References 1 Meijer P, Haverkate F, Kluft C. et al. A model for the harmonisation of test results of different quantitative D-dimer methods. Thromb Haemost 2006; 95: 567-72. 2 Nieuwenhuizen W. A reference material for harmonisation of D-dimer assays. Fibrinogen Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Thromb Haemost 1997; 77: 1031-3. 3 Dempfle CE, Zips S, Ergul H. et al. The Fibrin Assay Comparison Trial (FACT): evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators. FACT study group. Thromb Haemost 2001; 85: 671-8. 4 Gaffney PJ. Distinction between fibrinogen and fibrin degradation products in plasma. Clin Chim Acta 1975; 65: 109-15. 5 Rylatt DB, Blake AS, Cottis LE. et al. An immunoassay for human D dimer using monoclonal antibodies. Thromb Res 1983; 31: 767-78. 6 Walker KZ, Milner LJ, Bautovich GJ. et al. Detection of experimental thrombi in rabbits with an 131I-la-belled fibrin-specific monoclonal antibody. EurJ Nucl Med 1990; 16: 787-94. 7 Elms MJ, Bunce IH, Bundesen PG. et al. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies. Thromb Haemost 1983; 50: 591-4. 8 Rowbotham BJ, Carroll P, Whitaker AN. et al. Measurement of crosslinked fibrin derivatives--use in the diagnosis of venous thrombosis. Thromb Haemost 1987; 57: 59-61. 9 Gron B, Bennick A, Nieuwenhuizen W. et al. Normal and fibrinaemic patient plasma contain high-molecular weight crosslinked fibrin(ogen) derivatives with intact fibrinopeptide A. Thromb Res 1990; 57: 259-70. 10 Pfitzner SA, Dempfle CE, Matsuda M. et al. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A. Thromb Haemost 1997; 78: 1069-78. 11 Gaffney PJ. Fibrin degradation products. A review of structures found in vitro and in vivo . Ann N Y Acad Sci 2001; 936: 594-610. 12 Gron B, Filion-Myklebust C, Bennick A. et al. Early cross-linked fibrin in human plasma contains alpha-polymers with intact fibrinopeptide A. Blood Coagul Fibrinolysis 1992; 03: 731-6. 13 Marder VJ. What does the ‘dimertest’ test?. Circulation 1990; 82: 1514-5. 14 Francis CW, Marder VJ, Barlow GH. Plasmic degradation of crosslinked fibrin. Characterization of new macromolecular soluble complexes and a model of their structure. J Clin Invest 1980; 66: 1033-43. 15 Walker JB, Nesheim ME. The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin. J Biol Chem 1999; 274: 5201-12.
